Pulling the memo together.
Fetching live price, fundamentals, analyst consensus, and news.
Fetching live price, fundamentals, analyst consensus, and news.
Buy rating, composite score 8/10 at $521.08 (-11.87 (-2.23%)). Full scorecard, fundamentals, technicals, sentiment, risks, and catalysts below — or look up a different ticker.
| Dimension | Score | Key Signal |
|---|---|---|
| Fundamentals | 8/10 | healthy revenue growth (+18% YoY); excellent margins (40.3%) |
| Technicals | 8/10 | textbook uptrend (price > 50d > 200d); strong 90-day momentum (+30%) |
| Sentiment / News | 8/10 | 62 of 65 analysts bullish — strong consensus buy |
| Composite | 8/10 | Rating: Buy |
Microsoft Corp (Technology) trades at $521.08 with a market capitalization of $3.87T.
Revenue grew +17.8% year-over-year on a trailing basis. Trailing net profit margin sits at 40.3%. At a trailing P/E of 29.4, the market is pricing in moderate growth expectations. The balance sheet carries a debt-to-equity ratio of 0.24 — a notably clean capital structure.
The 52-week range spans $349.20 to $553.72. Current price sits -5.9% from the high and +49% from the low — a controlled pullback from recent highs.
Price sits above both the 50-day ($507.88) and 200-day ($436.31) moving averages, with the 50-day itself above the 200-day — a textbook uptrend structure. The 14-day RSI at 50.5 is in neutral territory. MACD histogram is negative at -1.91, indicating waning short-term momentum.
Performance: 30-day return +5.8%, 90-day +30.3%, 1-year +0.7%. Maximum drawdown over the trailing year reached -34.9%. Annualized volatility sits at 32.6% — elevated but not extreme, typical of growth names.
As of 2026-10-01, 65 analysts cover MSFT: 22 Strong Buy, 40 Buy, 3 Hold, 0 Sell, 0 Strong Sell. The consensus skew is decisively bullish. Bullish coverage has contracted versus the prior month — worth watching.
The most recent earnings (2026-06-30) beat expectations: actual EPS of $4.74 versus consensus of $4.33 (+0.41 surprise). A 9.5% positive surprise.
The composite rating of Buy (8/10) reflects strength across fundamentals, technicals, and analyst sentiment. Thesis breaks if analyst revisions turn sharply negative or earnings execution falters.